Company / Depreciation & Amortization
Alkermes plc Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$27.2M
FY2025
5-year range
$27.2M / $78.7M
FY2021-FY2025
Trend
-4.8%
vs FY2024
Sector context
#40 of 168
Health Care
What the data says
Alkermes plc's depreciation & amortization of $27M is higher than 76% of companies in the Health Care sector (FY2025). Depreciation & Amortization has declined for 5 consecutive years, from $82M in FY2020 to $27M in FY2025.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of -19.8%. Top quartile in the Health Care sector.
Improved from $75M to $27M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -29.6%
- 5-Year CAGR
- -19.8%
- 10-Year CAGR
- -
Sector benchmark
-87.2% below sector average
Key checks
Key Insights
- Alkermes plc's depreciation & amortization has declined for 5 consecutive years.
- 5-year CAGR of -19.8%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 4.8% year-over-year.
- Ranks #40 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 22.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.2M | -4.8% |
| FY2024 | $28.5M | -61.9% |
| FY2023 | $74.9M | -3.8% |
| FY2022 | $77.9M | -1.0% |
| FY2021 | $78.7M | -3.9% |
| FY2020 | $81.9M | +1.8% |
| FY2019 | $80.4M | -22.4% |
| FY2018 | $103.7M | +5.2% |
| FY2017 | $98.5M | +4.5% |
| FY2016 | $94.3M | +33.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026